Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 08-2021 | 08-2020 | 08-2019 | 08-2018 | 08-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 77,245 | 19,296 | 3,329 | 4,996 | 3,985 |
| Marketable Securities | 16,895 | 20,604 | 28,953 | 25,467 | 16,153 |
| TOTAL | $95,337 | $40,511 | $33,324 | $31,037 | $20,297 |
| Non-Current Assets | |||||
| PPE Net | 397 | 99 | 24 | 17 | 18 |
| Investments And Advances | 31,708 | 3,930 | 1,296 | 16,327 | 18,383 |
| Other Non-Current Assets | 557 | 93 | 19 | 16 | 14 |
| TOTAL | $32,662 | $4,122 | $1,339 | $16,360 | $18,415 |
| Total Assets | $127,999 | $44,633 | $34,663 | $47,397 | $38,712 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,846 | 1,789 | 2,605 | 2,104 | 2,716 |
| TOTAL | $6,679 | $4,536 | $5,308 | $4,553 | $5,165 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,703 | 2,703 | 2,703 | 2,449 | 2,449 |
| Other Non-Current Liabilities | 1,310 | 271 | 304 | 344 | 472 |
| TOTAL | $4,803 | $7,218 | $9,962 | $11,732 | $14,309 |
| Total Liabilities | $11,482 | $11,754 | $15,270 | $16,285 | $19,474 |
| Shareholders' Equity | |||||
| Common Shares | 424 | 284 | 208 | 207 | 163 |
| Retained earnings | -114,852 | -92,614 | -81,103 | -69,223 | -56,496 |
| Other shareholders' equity | 744 | 0 | 0 | 702 | 401 |
| TOTAL | $116,517 | $32,879 | $19,393 | $31,112 | $19,238 |
| Total Liabilities And Equity | $127,999 | $44,633 | $34,663 | $47,397 | $38,712 |